Pages
Update (21 June 2024): Ripley and Ilkeston Urgent Treatment Centres
https://dchs.nhs.uk/news/update-21-june-2024-ripley-and-ilkeston-urgent-treatment-centres
Storm Babet – service updates/disruption
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/storm-babet-service-updatesdisruption
DCHS inclusion conference 2023
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/dchs-inclusion-conference-2023
Files
PGD 152C Morphine Sulfate Oral Solution for Children (UTC).pdf
PGD 152C Morphine Sulphate for Children (UTC)
Dementia Palliative Care Service Patient Leaflet – Transitional Nurse (L331)
Dementia Palliative Care Service Patient Leaflet – Transitional Nurse
L334 - North East Derbyshire Type 2 Diabetes Education and Support
North East Derbyshire Type 2 Diabetes Education and Support (L334)
A7 - Administration of Enteral Feed Product (P48)
Administration of Enteral Feed Product
Locked Box Pathway (G335)
Locked Box Pathway
Disclosure Ref 202542 - Internal review investigation report Jan 25 1 of 2.pdf
Freedom of Information disclosure ref 202542 Internal review investigation report Jan 25 1 of 2
Disclosure Ref 202592 - Mechanical Ventilation & MRIs.pdf
Freedom of information disclosure reference 202592 relating to Mechanical Ventilation & MRIs
Disclosure Ref 2025107 - Administrating Injections 1st Jan 2020 to 15 Mar 2025 .pdf
FOI disclosure ref 2025/107 regarding the administration of injections to patients without their consent within the Trust.
Disclosure Ref 2024202 - International Healthcare Recruitment Campaigns.pdf
Freedom of Information disclosure reference 2024/202 relating to international recruitment campaigns including insight into the professions being recruited, appointed agency, framework utilised and Contract expiry
Flu Vaccine - FAQ information for DCHS staff 2025-26 (G346)
The document provides comprehensive information about the flu vaccine for DCHS staff for the 2025-26 season. It addresses various frequently asked questions (FAQs) related to the administration of the flu vaccine, including eligibility criteria, safety for specific groups (such as pregnant women, individuals with egg or latex allergies, and those with religious or dietary restrictions), and guidelines for staff who are administering the vaccine. The document also provides information on handling the vaccine, necessary personal protective equipment (PPE), and procedures for dealing with anaphylaxis. Additionally, the document includes resources and standard operating procedures (SOPs) for staff involved in the vaccination process.